Corrections Noted in Table 2 of the Study on Ixekizumab and Tirzepatide for Psoriasis in Adults with Overweight or Obesity
-
July 1, 2026
July 1, 2026
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
June 11, 2026
Genetically predicted triglyceride levels were associated with higher odds of psoriasis, while genetically predicted total fatty acid levels were not, in a two-sample Mendelian randomization analysis.
June 26, 2026